Valuation -- 6/10

MDB trades at a discount to cloud peers (SNOW, DDOG) on EV/Revenue, reflecting its newer CEO/management transition, lower FCF margins, and still-GAAP-unprofitable status. However, the PEG of 0.35 is the most attractive in the peer set, suggesting meaningful upside if growth sustains. The stock currently trades 19% below its 50-day and 200-day moving averages (~$312), indicating severe near-term de-rating from macro/tariff fears and the go-to-market leadership change announced on the FQ4 call. Weight: 15%
EV/Revenue
7.3x
discount to SNOW (14x) and DDOG (18x)
Forward P/E
43x
vs SNOW 70x, DDOG 55x, ORCL 25x
PEG Ratio
0.35
most attractive in peer set
Prob-Weighted Fair Value
~$295
~17% upside from $253 current price
Peer valuation comparison
Company EV/Revenue Forward P/E Rev Growth Non-GAAP Op Margin FCF Margin Rule of 40
MongoDB (MDB) 7.3x 43x +23% ~18% ~20% ~41
Snowflake (SNOW) ~14x ~70x +28% ~8% ~28% ~36
Datadog (DDOG) ~18x ~55x +27% ~25% ~30% ~52
Oracle (ORCL) ~9x ~25x +10% ~44% ~35% ~53
Key Takeaway MDB trades at a significant discount to SNOW and DDOG on EV/Revenue despite comparable growth rates. The PEG of 0.35 is the most attractive in the peer set. The discount reflects management transition risk, lower FCF margins, and GAAP unprofitability -- but the gap appears overdone given the beat-and-raise track record.
Peer multiples are approximate and based on consensus estimates. MDB data as of March 2026 post-earnings. Data sourced from Daloopa and public filings.

Scenario analysis
Scenario Probability Price Target Key Driver
Bull 25% $380-$420 AI agents drive incremental workloads; new CRO exceeds expectations; Atlas sustains 25%+ growth
Base 50% $280-$330 FY27 revenue 16-18%, margin expansion on plan, CRO transition smooth
Bear 25% $175-$220 Go-to-market disruption, enterprise spending cuts, PostgreSQL wins mindshare; multiple compresses to 5-6x EV/Revenue
Probability-weighted fair value: ~$295 vs. current $253, implying ~17% upside. Bear case of $175-$220 reflects multiple compression to 5-6x EV/Revenue (consistent with the 2022 software drawdown trough).

Key catalysts (bull case)
# Catalyst Detail
1 Atlas Reacceleration Atlas grew from +24% to +30% YoY over FY26, crossing the $2B run rate. Record $502.6M quarterly revenue in FQ4. Net ARR expansion rose to 121%. Conservative FY27 guide of 21-23% leaves room for beats given the track record.
2 AI/Agentic Positioning Atlas Vector Search customers nearly doubled YoY. Named customers include Anthropic, ElevenLabs, and Mercor. Document model has structural advantage for unstructured AI data. Positioning as "Postgres + Elastic + Pinecone + Cohere in one platform."
3 Enterprise Advanced Renaissance EA grew 20% in FQ4 -- best in 2 years. Signed >$100M TCV deal with a large financial institution (largest in MDB history) and ~$90M deal with a large tech company. RPO nearly doubled to $1.47B (+97% YoY).
4 FCF Inflection to Buybacks FCF improved to $493M (20% margin) from $115M prior year (+330% YoY). Company committing 100% of FCF to buybacks + RSU tax settlements. Cash conversion exceeded 100% in FY26.
5 Customer Base Deepening $1M+ ARR customers reached 402 (+26% YoY). 44% of large Atlas customers use 2+ platform features (up from 36% a year ago). Total customers grew +20% to 65,200.

Key risks (bear case)
# Risk Severity Detail
1 CRO/President Departures HIGH Both President of Field Ops (Cedric Pech) and CRO (Paul Keppambesis) departed March 2026 -- a decade of institutional knowledge lost simultaneously. CRO search still ongoing. Happening under a CEO with only ~100 days in role. Historically causes 1-2 quarter execution hiccups.
2 PostgreSQL Competitive Threat MED-HIGH PostgreSQL holds 55.6% developer usage vs. MDB at 24%. pgvector 0.8 narrowed the vector search gap to ~95% recall. Every hyperscaler offers managed PostgreSQL. AI coding agents may default to Postgres as the more familiar choice.
3 AI Revenue Not Yet Material MEDIUM CEO CJ Desai was explicit: "AI is not yet a material driver to our results." Management declined to quantify AI-attributed revenue. Vector search adoption is growing but off a small base. Risk of narrative inflating expectations beyond deliverables.
4 Gross Margin Headwind LOW-MED Non-GAAP gross margin declined from 77% to 74-75% as Atlas (lower margins from cloud hosting costs) grows as a share of revenue. Atlas is now 72-75% and rising, creating a structural headwind to overall gross margins.
5 MongoBleed Vulnerability MEDIUM CVE-2025-14847 (CVSS 8.7) discovered Dec 2025. CISA added to Known Exploited Vulnerabilities catalog. 213,000+ internet-exposed instances identified. Could slow enterprise adoption in security-conscious industries.
6 GAAP Profitability Elusive LOW GAAP net loss of -$71M in FY26 due to ~$500M+ in SBC (23% of revenue). While non-GAAP margins are expanding rapidly, SBC remains a material dilution factor that limits multiple expansion.

Score rationale

Score of 6/10 reflects reasonable valuation versus cloud peers with real catalysts, but meaningful execution risk from leadership transition and Postgres competition.

Why not higher (7-8): At 7.3x EV/Revenue and 43x forward P/E, MDB is cheaper than SNOW/DDOG but still expensive relative to its own history (5-6x during the 2022 software drawdown) and the broader software market. FY27 guided revenue growth of 16-18% represents meaningful deceleration from FY26 at 22.8%. The concentrated C-suite turnover -- CEO, CRO, and President all transitioning -- is atypical for a $2.5B company and adds execution risk that could compress the multiple further. AI revenue contribution remains narrative, not reality. GAAP unprofitability from $500M+ SBC limits institutional appetite.

Why not lower (4-5): The PEG of 0.35 is genuinely attractive and the most compelling in the peer set. The -22% single-day selloff on conservative FY27 guidance creates a real dislocation given management consistently beats their own targets (14 promises: 8 BEAT, 5 MET, 1 PARTIAL, 0 MISSED). FCF inflection to $493M with 100% committed to buybacks provides downside support. Atlas reacceleration from +24% to +30% at $2B+ scale is rare. Analyst consensus remains bullish at 28/34 Buy+ with $369 target (+46% upside). The probability-weighted fair value of ~$295 implies ~17% upside from current levels.

Net assessment: MDB offers an attractive entry point for patient investors willing to underwrite the management transition. Accumulate on further weakness toward $220-230 where risk/reward becomes compelling.

Data sourced from Daloopa and public filings. Analysis as of March 2026.